secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neumora Therapeutics, Inc. (NMRA)
CIK:        0001885522
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001193125-25-004999
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neumora Therapeutics presents at J.P. Morgan Healthcare Conference; no specific data disclosed in filing exhibit
--------------------------------------------------------------------------------

- Corporate presentation made available for J.P. Morgan Healthcare Conference on Jan 13, 2025.
- Presentation titled "Redefining Neuroscience Drug Development" but full content not provided.
- No financial or pipeline updates explicitly stated in the 8-K exhibit snippet.
- Confidence low due to incomplete exhibit text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1885522/000119312525004999/0001193125-25-004999-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1885522/000119312525004999/d906757d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-004999

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer